Literature DB >> 26987492

Thrombosis of the Cerebral Veins and Sinuses in Hamadan, West of Iran.

Masoud Ghiasian1, Maryam Mansour2, Shahir Mazaheri3, Azar Pirdehghan4.   

Abstract

BACKGROUND AND
PURPOSE: Cerebral venous sinuses thrombosis (CVST) is an uncommon type of stroke with an incidence of 3-4 cases per million. There have been reports of higher incidence of this disease in Iran. Our objective is to describe the incidence, clinical presentation, predisposing factors, and outcomes of CVST at Sina Hospital in Hamadan, west of Iran.
METHODS: This is a prospective, single-center, longitudinal study of all patients referred to Sina Hospital in Hamadan, west of Iran, between May 2009 to May 2015 who were diagnosed with CVST.
RESULTS: In this study, 151 patients were included. There were 118 women and 33 men. The mean age was 37.48 years. The mean incidence rate of CVST in the duration of our study was 13.49 per 1 million. Oral contraceptives, the most common risk factor, were used by 55.1% of women and half of these patients had fasting simultaneously. Fifty-eight patients had more than 1 risk factor. After 12 months' follow-up, 73.1% of the patients were functionally independent (mRS score 0-1). Ten percent were dependent. The overall mortality was 16.9%.
CONCLUSIONS: The incidence of CVST in Hamadan is higher than the world's average, and overall outcome is worse. It seems that fasting and subsequent dehydration in women with recent use of oral contraceptives make them more susceptible to CVST.
Copyright © 2016 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebral venous thrombosis; Iran; incidence; risk factors

Mesh:

Substances:

Year:  2016        PMID: 26987492     DOI: 10.1016/j.jstrokecerebrovasdis.2016.02.022

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  3 in total

1.  Trends in incidence and epidemiologic characteristics of cerebral venous thrombosis in the United States.

Authors:  Fadar Oliver Otite; Smit Patel; Richa Sharma; Pushti Khandwala; Devashish Desai; Julius Gene Latorre; Emmanuel Oladele Akano; Nnabuchi Anikpezie; Saef Izzy; Amer M Malik; Dileep Yavagal; Priyank Khandelwal; Seemant Chaturvedi
Journal:  Neurology       Date:  2020-08-26       Impact factor: 9.910

2.  The Hospitalization Rate of Cerebral Venous Sinus Thrombosis before and during COVID-19 Pandemic Era: A Single-Center Retrospective Cohort Study.

Authors:  Maryam Vasaghi Gharamaleki; Maryam Habibagahi; Etrat Hooshmandi; Reza Tabrizi; Shahram Arsang-Jang; Zohreh Barzegar; Nima Fadakar; Vahid Reza Ostovan; Abbas Rahimi-Jaberi; Nahid Ashjazadeh; Peyman Petramfar; Maryam Poursadeghfard; Sadegh Izadi; Masoumeh Nazeri; Hanieh Bazrafshan; Zahra Bahrami; Sedigheh Karimlu; Seyedeh Shaghayegh Zafarmand; Mahnaz Bayat; Mohammad Saied Salehi; Maryam Owjfard; Saeideh Karimi-Haghighi; Anahid Safari; Banafsheh Shakibajahromi; Beng Lim Alvin Chew; Bradford B G Worral; Jonathan M Coutinho; Carlos Garcia-Esperon; Neil Spratt; Christopher Levi; Mahmoud Reza Azarpazhooh; Afshin Borhani-Haghighi
Journal:  J Stroke Cerebrovasc Dis       Date:  2022-03-25       Impact factor: 2.677

3.  Clinical presentations, radiological characteristics, and biological risk factors of cerebral venous thrombosis at a University Hospital in Saudi Arabia.

Authors:  Abdullah S Alamri; Mohammed F Almuaigel; Zafar Azra; Foziah J Alshamrani; Noor M AlMohish; Mona H AlSheikh
Journal:  Saudi Med J       Date:  2021-02       Impact factor: 1.484

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.